Our results confirm that c-Met and PI3K are significantly overexpressed in IBC, suggesting that in this particular clinical setting, c-Met expression and downstream signal transducers may be regarded as potential targets for specific therapies. Here, MET is linked to inflammatory breast carcinoma.